Perspective Therapeutics (FRA:AAJ0) FCF Margin %: 0.00% (As of Mar. 2026)


FRA:AAJ0 Perspective Therapeutics Inc FRA:AAJ0
31 GF Score
Price €2.56
! 1 Warning Sign
View Full Analysis

What is Perspective Therapeutics FCF Margin %?

Perspective Therapeutics FRA:AAJ0 +3.72% 31 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:AAJ0 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Perspective Therapeutics ranks worse than 122699.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Perspective Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was €-33.15 Mil. Perspective Therapeutics's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Perspective Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Perspective Therapeutics's current FCF Yield % is -31.37%.

The historical rank and industry rank for Perspective Therapeutics's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Perspective Therapeutics was -32.01%. The lowest was -131.51%. And the median was -75.10%.

FRA:AAJ0's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.1
* Ranked among companies with meaningful FCF Margin % only.

Perspective Therapeutics FCF Margin % Related Terms

Perspective Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Perspective Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics FCF Margin % Chart

Perspective Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.01 -73.89 0.00 0.00 0.00

Perspective Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:AAJ0 vs LAB, KIDS, PACB: FCF Margin % Comparison

For the Medical Devices subindustry, Perspective Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perspective Therapeutics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's FCF Margin % falls into.


FRA:AAJ0
31GF Score
Perspective Therapeutics Inc FRA:AAJ0
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perspective Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Perspective Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-81.329/0
= %

Perspective Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-33.152/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Perspective Therapeutics (FRA:AAJ0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Perspective Therapeutics and its competitors. According to the industry distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Perspective Therapeutics' FCF Margin % too high?
Perspective Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Perspective Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' FCF Margin % compare to LAB and KIDS?
According to the Medical Devices & Instruments industry distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies for FCF Margin %. This places Perspective Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Perspective Therapeutics and its competitors. Perspective Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Perspective Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Perspective Therapeutics Business Description

Other Exchanges CATX:USA
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
31GF Score

Get the complete analysis for FRA:AAJ0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.56
Price